This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $635,218.92 and a period of performance ending on November 19, 2024. The award is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a major pharmaceutical supplier to federal agencies, providing critical medical products including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs to various government healthcare programs. This award is unrestricted, meaning Teva competed as a large business without any set-aside designation.
Generated 2/13/25, 9:25 AM